Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal
申请人:Janssen Pharmaceutica N.V.
公开号:US04906643A1
公开(公告)日:1990-03-06
N-(3-hydroxy-4-piperidinyl)substituted benzamides, their N-oxide forms and pharmaceutically acceptable acid-addition salts having gastrointestinal motility stimulating properties, compositions containing the same, and methods of treating warm blooded animals suffering from a decreased peristalsis of the gastrointestinal system.
The use for the manufacture of a medicament for the treatment of diarrhea of a compound of formula
wherein Ar is thienyl, halothienyl, furanyl, halofuranyl, pyridinyl, aminopyridinyl, thiazolyl, imidazolyl or a radical of formula
and Ar1 and Ar2 are, each independently, phenyl or halophenyl; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions; novel compounds of formula (I).
用于制造治疗腹泻的药物的式化合物 其中 Ar 是噻吩基、卤代噻吩基、呋喃基、卤代呋喃基、吡啶基、氨基吡啶基、噻唑基、咪唑基或式中的自由基,Ar1 和 Ar2 各自独立地是苯基或卤代苯基;药学上可接受的酸加成盐及其可能的立体化学异构形式;含有此类化合物作为活性成分的药物组合物以及制备所述化合物和药物组合物的方法;式 (I) 的新型化合物。